Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Some genetic melanocortin-1 receptor (MC1R) variants responsible for human red hair color (RHC-variants) are consequently associated with increased melanoma risk. Although MC1R signaling is critically dependent on its palmitoylation primarily mediated by the ZDHHC13 protein-acyl transferase, whether increasing MC1R palmitoylation represents a viable therapeutic target to limit melanomagenesis in redheads is unknown. Here we identify a specific and efficient in vivo strategy to induce MC1R palmitoylation for therapeutic benefit. We validate the importance of ZDHHC13 to MC1R signaling in vivo by targeted expression of ZDHHC13 in C57BL/6J-MC1RRHC mice and subsequently inhibit melanomagenesis. By identifying APT2 as the MC1R depalmitoylation enzyme, we are able to demonstrate that administration of the selective APT2 inhibitor ML349 treatment efficiently increases MC1R signaling and represses UVB-induced melanomagenesis in vitro and in vivo. Targeting APT2, therefore, represents a preventive/therapeutic strategy to reduce melanoma risk, especially in individuals with red hair.

Original publication

DOI

10.1038/s41467-019-08691-3

Type

Journal article

Journal

Nat Commun

Publication Date

20/02/2019

Volume

10

Keywords

Acyltransferases, Animals, Carcinogenesis, Cell Line, Genetic Predisposition to Disease, HEK293 Cells, Hair Color, Humans, Lipoylation, Melanocytes, Melanoma, Mice, Mice, Inbred C57BL, Mice, Nude, Mice, Transgenic, Receptor, Melanocortin, Type 1, Signal Transduction, Thiolester Hydrolases